Relx (NYSE:RELX) Reaches New 52-Week High – Here’s What Happened

Relx Plc (NYSE:RELX) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $51.09 and last traded at $51.01, with a volume of 34952 shares. The stock had previously closed at $50.56.

Analyst Upgrades and Downgrades

RELX has been the subject of several research reports. StockNews.com initiated coverage on Relx in a report on Wednesday, October 30th. They issued a “hold” rating for the company. Redburn Atlantic started coverage on Relx in a report on Wednesday, January 8th. They issued a “buy” rating on the stock.

Relx Stock Up 0.3 %

The company’s 50-day simple moving average is $47.66 and its 200 day simple moving average is $47.09. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63.

Institutional Investors Weigh In On Relx

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new stake in Relx in the fourth quarter valued at about $44,516,000. Arrowstreet Capital Limited Partnership increased its stake in Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after purchasing an additional 658,655 shares in the last quarter. FMR LLC raised its holdings in shares of Relx by 8.3% in the third quarter. FMR LLC now owns 7,148,837 shares of the technology company’s stock worth $339,284,000 after buying an additional 548,423 shares during the last quarter. Mediolanum International Funds Ltd acquired a new stake in shares of Relx during the third quarter worth $12,902,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Relx during the fourth quarter valued at $9,920,000. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.